Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area.
In 2018, the global Tumor Radiofrequency Ablation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Tumor Radiofrequency Ablation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Radiofrequency Ablation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Boston Scientific
Diros Technology
Halyard Health
St. Jude Medical
Cosman Medical
Medtronic
NeuroTherm
Stryker
Cosman Medical

Market segment by Type, the product can be split into
Lung Cancer
Kidney Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Others

Market segment by Application, split into
Hospitals
Cancer Specialty Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tumor Radiofrequency Ablation status, future forecast, growth opportunity, key market and key players.
To present the Tumor Radiofrequency Ablation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tumor Radiofrequency Ablation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.